Investor Relations

Financial calendar


 

Subscribe to calendar

Latest press releases

Notice to attend the Annual General Meeting in ExpreS2ion Biotech Holding AB (publ)

N.B. This notice has been prepared in both Swedish and English language versions. In the event of any discrepancies between the versions, the Swedish version shall prevail. The shareholders of ExpreS2ion Biotech Holding AB (publ), reg. no. 559033-3729 (the "Company"), are hereby given notice to attend the Annual General Meeting to be held on 28…

Read more

Kallelse till årsstämma i ExpreS2ion Biotech Holding AB (publ)

Aktieägarna i ExpreS2ion Biotech Holding AB (publ), org.nr 559033-3729 ("Bolaget"), kallas härmed till årsstämma den 28 maj 2025 klockan 10.30 på Mindpark, Bredgatan 11, i Helsingborg. Inpassering och registrering till stämman startar klockan 10.00.

Read more

ExpreS2ion signs Letter of Intent with WuXi Vaccines to initiate technology evaluation of ExpreS2ion’s proprietary production platform ExpreS2™

Hørsholm, Denmark, 15 April 2025 - ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), today announced that ExpreS2ion and WuXi Vaccines have signed a Letter of Intent to initiate a technology evaluation of ExpreS2ion’s proprietary Drosophila S2 expression technology platform (“ExpreS2”) for the bioproduction of vaccines and other biologics. WuXi Vaccines is a World-leading…

Read more

Latest presentations

2024 Q4 and Full-Year
Report Webcast

6 February 2025

Stora Aktiedagarna
Stockholm

27 November 2024

Biostock
Life Science Summit

21 November 2024